Enhanced Green Fluorescent Protein, EGFP (200-208) - 1 mg
- Cat.Number : AS-65302
- Manufacturer Ref. :
-
Availability :
In production
This peptide is H2-Kd-restricted enhanced green fluorescent protein (EGFP)-derived peptide (200-208) and represents a CD8 T cell epitope. Immunization with this peptide stimulates IFNg production, thus making this peptide a model tumor antigen for the experimental development of antigen-specific vaccines against cancer.
Specifications
| Chemistry | |
| Sequence one letter code |
|
|---|---|
| Sequence three letter code |
|
| Molecular Formula |
|
| Molecular Mass/ Weight |
|
| Modification | |
| Conjugation |
|
| Quantity & Purity | |
| Purity |
|
| Storage & stability | |
| Form |
|
| Storage Conditions |
|
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage |
|
| Source | |
| Source / Species |
|
You may also be interested in the following product(s)
SensoLyte® Rh110 Matriptase Activity Assay Kit Fluorimetric - 1 kit
References
Captopril, an Angiotensin-Converting Enzyme Inhibitor, Promotes Growth of Immunogenic Tumors in Mice
Clin Cancer Res . 2006 Jul 01 ; 12(13) 4095 | DOI : 10.1158/1078-0432.CCR-05-2489
- P. Wysocki
- et al
High Accumulation of T Regulatory Cells Prevents the Activation of Immune Responses in Aged Animals
J Immunol . 2006 Dec 15 ; 177(12) 8348 | DOI : https://doi.org/10.4049/jimmunol.177.12.8348
- S. Sharma
- et al
Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope
Gene Ther . 2000 Dec 04 ; 7(23) 2036 | DOI : https://doi.org/10.1038/sj.gt.3301335
- A. Gambotto
- et al
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO
Eur J Immunol . 2005 Dec 27 ; 36(1) 12 | DOI : https://doi.org/10.1002/eji.200535602
- W. Wingender
- et al